AAAAAA
Results:
1-14
|
Results: 14
Authors:
Nielsen, OS
Citation: Os. Nielsen, Present status of palliative radiotherapy, EUR J CANC, 37, 2001, pp. S279-S288
Authors:
Nielsen, OS
Horsman, M
Overgaard, J
Citation: Os. Nielsen et al., A future for hyperthermia in cancer treatment?, EUR J CANC, 37(13), 2001, pp. 1587-1589
Authors:
van Oosterom, AT
Judson, I
Verweij, J
Stroobants, S
di Paola, ED
Dimitrijevic, S
Martens, M
Webb, A
Sciot, R
Van Glabbeke, M
Silberman, S
Nielsen, OS
Citation: At. Van Oosterom et al., Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase I study, LANCET, 358(9291), 2001, pp. 1421-1423
Authors:
Nordsmark, M
Alsner, J
Keller, J
Nielsen, OS
Jensen, OM
Horsman, MR
Overgaard, J
Citation: M. Nordsmark et al., Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations, BR J CANC, 84(8), 2001, pp. 1070-1075
Authors:
Vraa, S
Keller, J
Nielsen, OS
Jurik, AG
Jensen, OM
Citation: S. Vraa et al., Soft-tissue sarcoma of the thigh - Surgical margin influences local recurrence but not survival in 152 patients, ACT ORTH SC, 72(1), 2001, pp. 72-77
Authors:
Nielsen, OS
Judson, I
van Hoesel, Q
le Cesne, A
Keizer, HJ
Blay, JY
van Oosterom, A
Radford, JA
Svancarova, L
Krzemienlecki, K
Hermans, C
van Glabbeke, M
Oosterhuis, JW
Verweij, J
Citation: Os. Nielsen et al., Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, EUR J CANC, 36(1), 2000, pp. 61-67
Authors:
Gwyther, SJ
Nielsen, OS
Judson, IR
van Glabbeke, M
Verweij, J
Citation: Sj. Gwyther et al., Radiologist review versus group peer review of claimed responses in a phase II study on high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the EORTC Soft Tissue and Bone Sarcoma Group, ANTI-CANC D, 11(6), 2000, pp. 433-437
Authors:
Safwat, A
Bentzen, SM
Nielsen, OS
Overgaard, J
Citation: A. Safwat et al., Time-course of the hazard of murine nephropathy induced by total-body irradiation, INT J RAD B, 76(7), 2000, pp. 979-983
Authors:
Bentzen, SM
Hoskin, P
Roos, D
Nielsen, OS
Citation: Sm. Bentzen et al., Fractionated radiotherapy for metastatic bone pain: Evidence-based medicine or ...?, INT J RAD O, 46(3), 2000, pp. 681-682
Authors:
Woll, PJ
Judson, I
Lee, SM
Rodenhuis, S
Nielsen, OS
Buesa, JM
Lorigan, PC
Leyvraz, S
Hermans, C
van Glabbeke, M
Verweij, J
Citation: Pj. Woll et al., Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group, EUR J CANC, 35(3), 1999, pp. 410-412
Authors:
Nielsen, OS
Citation: Os. Nielsen, Palliative radiotherapy of bone metastases: there is now evidence for the use of single fractions, RADIOTH ONC, 52(2), 1999, pp. 95-96
Authors:
Stausbol-Gron, B
Bentzen, SM
Jorgensen, KE
Nielsen, OS
Bundgaard, T
Overgaard, J
Citation: B. Stausbol-gron et al., In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data, BR J CANC, 79(7-8), 1999, pp. 1074-1084
Authors:
Vraa, S
Keller, J
Nielsen, OS
Sneppen, O
Jurik, AG
Jensen, OM
Citation: S. Vraa et al., Prognostic factors in soft tissue sarcomas: The Aarhus experience, EUR J CANC, 34(12), 1998, pp. 1876-1882
Authors:
Nielsen, OS
Dombernowsky, P
Mouridsen, H
Crowther, D
Verweij, J
Buesa, J
Steward, W
Daugaard, S
van Glabbeke, M
Kirkpatrick, A
Tursz, T
Citation: Os. Nielsen et al., High-dose epirubicin is not an alternative to standard-dose doxorubicin inthe treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group, BR J CANC, 78(12), 1998, pp. 1634-1639
Risultati:
1-14
|